| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.27 | 0.05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |